Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients (Q34408625)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Sandra Steffens

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Astrid Köhler

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Raphael Rudolph

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hendrik Eggers

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Christoph Seidel

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Martin Janssen

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gerd Wegener

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Mark Schrader

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Markus A Kuczyk

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Andres J Schrader

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

8 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

399

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3502607

6 July 2018

Biomarkers in clear cell renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3502607

6 July 2018

A systematic review of the association between circulating concentrations of C reactive protein and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3502607

6 July 2018

The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3502607

6 July 2018

Metastatic renal carcinoma comprehensive prognostic system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3502607

6 July 2018

Renal-cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3502607

6 July 2018

Management of distant solitary recurrence in the patient with renal cancer. Contralateral kidney and other sites.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3502607

6 July 2018

Interleukin-6 and renal cell cancer: production, regulation, and growth effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3502607

6 July 2018

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3502607

6 July 2018

C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-399

21 January 2018

Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-399

21 January 2018

Plasma C-reactive protein and risk of cancer: a prospective study from Greece.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-399

21 January 2018

The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-399

21 January 2018

Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-399

21 January 2018

Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-399

21 January 2018

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new protocol for the followup of renal cell carcinoma based on pathological stage

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant prognostic factors for 5-year survival after curative resection of renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic inflammatory response, prostate-specific antigen and survival in patients with metastatic prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How do symptoms have an impact on the prognosis of renal cell carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22958305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-12-399

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34408625&oldid=2196595716"